Willingness-to-pay to access Ingenol Mebutate Gel for Actinic Keratosis Treatment in the U.S. Setting

# Background Currently available topical treatments for actinic keratosis (AK) adversely affect patients’ quality of life because of long treatment durations and long-lasting local skin reactions (LSRs), which may result in poor treatment adherence and patient outcomes. Ingenol mebutate gel, a recen...

Full description

Bibliographic Details

Published in:	Journal of Health Economics and Outcomes Research
Main Authors:	Michael Willis, Sandra Erntoft, Sofie Persson, Jenny M. Norlin, Ulf Persson
Format:	Article
Language:	English
Published:	Columbia Data Analytics, LLC 2014-10-01
Online Access:	https://doi.org/10.36469/9879